CDNA vs. XBI
Compare and contrast key facts about CareDx, Inc (CDNA) and SPDR S&P Biotech ETF (XBI).
XBI is a passively managed fund by State Street that tracks the performance of the S&P Biotechnology Select Industry Index. It was launched on Feb 6, 2006.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: CDNA or XBI.
Correlation
The correlation between CDNA and XBI is 0.43, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
CDNA vs. XBI - Performance Comparison
Key characteristics
CDNA:
2.36
XBI:
-0.01
CDNA:
3.04
XBI:
0.15
CDNA:
1.39
XBI:
1.02
CDNA:
2.04
XBI:
-0.01
CDNA:
8.47
XBI:
-0.03
CDNA:
22.15%
XBI:
9.40%
CDNA:
79.51%
XBI:
24.39%
CDNA:
-94.87%
XBI:
-63.89%
CDNA:
-75.54%
XBI:
-46.61%
Returns By Period
In the year-to-date period, CDNA achieves a 9.20% return, which is significantly higher than XBI's 2.95% return. Over the past 10 years, CDNA has outperformed XBI with an annualized return of 14.35%, while XBI has yielded a comparatively lower 2.79% annualized return.
CDNA
9.20%
3.00%
-24.48%
183.74%
-3.73%
14.35%
XBI
2.95%
2.44%
-7.39%
0.41%
-0.87%
2.79%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
CDNA vs. XBI — Risk-Adjusted Performance Rank
CDNA
XBI
CDNA vs. XBI - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for CareDx, Inc (CDNA) and SPDR S&P Biotech ETF (XBI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
CDNA vs. XBI - Dividend Comparison
CDNA has not paid dividends to shareholders, while XBI's dividend yield for the trailing twelve months is around 0.14%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CDNA CareDx, Inc | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
XBI SPDR S&P Biotech ETF | 0.14% | 0.15% | 0.02% | 0.00% | 0.04% | 0.20% | 0.00% | 0.28% | 0.24% | 0.26% | 0.61% | 1.07% |
Drawdowns
CDNA vs. XBI - Drawdown Comparison
The maximum CDNA drawdown since its inception was -94.87%, which is greater than XBI's maximum drawdown of -63.89%. Use the drawdown chart below to compare losses from any high point for CDNA and XBI. For additional features, visit the drawdowns tool.
Volatility
CDNA vs. XBI - Volatility Comparison
CareDx, Inc (CDNA) has a higher volatility of 18.28% compared to SPDR S&P Biotech ETF (XBI) at 5.62%. This indicates that CDNA's price experiences larger fluctuations and is considered to be riskier than XBI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.